Low opioid analgesic prescribing is achievable for patients undergoing hernia repair
TUESDAY, Aug. 15, 2017 (HealthDay News) — The number of opioids prescribed for patients after elective hernia repair can be reduced, according to a study published online Aug. 1 in Surgery.
Konstantinos S. Mylonas, M.D., from Massachusetts General Hospital in Boston, and colleagues surveyed 185 adult patients (95.7 percent male) undergoing elective inguinal herniorrhaphy under local anesthesia with intravenous sedation between Oct. 1, 2015, and Sept. 30, 2016. The surveys were conducted two to three weeks postoperatively and included questions about the institution’s opioid prescribing practice. Patients were prescribed 10 opioid analgesic tablets postoperatively but were counseled to reserve opioids for pain not controlled by nonopioid analgesics.
The researchers found that 85.9 percent of patients reported using four or fewer opioid tablets, with 59.5 percent reporting that they used no opioid analgesics postoperatively. Of the 147 employed patients, 75.5 percent reported missing three or fewer work days, with 51.4 percent missing no work at all. Patients who used no opioids reported experiencing less maximum (P < 0.001) and persistent groin pain (P = 0.037). They also reported that pain interfered less with daily activities (P = 0.012) and leisure activities (P = 0.018), compared to patients who did take opioids.
“Our data suggest that for elective inguinal hernia repair under a local anesthetic with intravenous sedation, a policy of low opioid analgesic prescribing is achievable,” the authors write.
Withdrawal From Medetomidine Increasingly Seen in ICUs
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported